- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有305家主力机构披露2024-12-31报告期持股数据，持仓量总计12.42亿股，占流通A股62.81%
- 波段诊断：
-
技术面诊股
诊断结果：3.6技术面打败了53%的股票
技术面评分前10的股票
近期的平均成本为19.66元。
平均成本
近期的平均成本为19.66元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"19.66","date":1752137992,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2025.07.11","stock":"-0.20","trade":"1.39","ind":"0.01"},{"date":"2025.07.10","stock":"0.05","trade":"0.92","ind":"0.48"},{"date":"2025.07.09","stock":"0.10","trade":"-0.28","ind":"-0.13"},{"date":"2025.07.08","stock":"-0.61","trade":"0.18","ind":"0.70"},{"date":"2025.07.07","stock":"2.01","trade":"-1.65","ind":"0.02"},{"date":"2025.07.04","stock":"-0.61","trade":"0.46","ind":"0.32"},{"date":"2025.07.03","stock":"1.61","trade":"2.86","ind":"0.18"},{"date":"2025.07.02","stock":"-0.10","trade":"-1.57","ind":"-0.09"},{"date":"2025.07.01","stock":"0.21","trade":"2.52","ind":"0.39"},{"date":"2025.06.30","stock":"0.05","trade":"1.47","ind":"0.59"},{"date":"2025.06.27","stock":"-0.62","trade":"0.85","ind":"-0.70"},{"date":"2025.06.26","stock":"0.26","trade":"-1.31","ind":"-0.22"},{"date":"2025.06.25","stock":"-0.16","trade":"0.29","ind":"1.03"},{"date":"2025.06.24","stock":"1.10","trade":"1.81","ind":"1.15"},{"date":"2025.06.23","stock":"-0.37","trade":"1.50","ind":"0.65"},{"date":"2025.06.20","stock":"0.53","trade":"0.27","ind":"-0.07"},{"date":"2025.06.19","stock":"0.00","trade":"-1.80","ind":"-0.79"},{"date":"2025.06.18","stock":"-0.98","trade":"-1.20","ind":"0.04"},{"date":"2025.06.17","stock":"0.05","trade":"-1.63","ind":"-0.04"},{"date":"2025.06.16","stock":"-0.57","trade":"-0.12","ind":"0.35"},{"date":"2025.06.13","stock":"-1.82","trade":"-2.82","ind":"-0.75"}]
天坛生物,上证指数,生物制品指数
压力支撑
该股压力位为19.64元，支撑位为19.58元。
[{"text":"\u538b\u529b\u4f4d","value":"19.64","date":1752163200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.58","date":1752163200,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.6资金面打败了42%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月11日 20:37
| 机构今日流向(万元) | 257.60 | 机构5日流向(万元) | -4328.58 |
| 机构10日流向(万元) | -2851.72 | 机构20日流向(万元) | -12336.71 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少14871.12万股，其中基金净减仓15家，主力净减仓143家，请投资者中长期谨慎为宜。
截止2024-12-31，共305家主力机构（基金300家，一般法人4家，社保基金1家），持仓量总计124190.64万股，占流通A股62.81%
其中，基金持仓与2024-06-30相比：
增仓：86家 ，增持 2781.92万股
减仓：101家 ，减持 6715.22万股
新出现在主力名单中：97家 ，持有4141.69万股
从主力名单中消失：240家 ，原持有11888.71万股
其中，基金持仓与2024-06-30相比：
增仓：86家 ，增持 2781.92万股
减仓：101家 ，减持 6715.22万股
新出现在主力名单中：97家 ，持有4141.69万股
从主力名单中消失：240家 ，原持有11888.71万股
消息面诊股
诊断结果：5.8消息面打败了47%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 行业周报|生物制品指数涨0.53%, 跑输上证指数
2025-07-11 - 天坛生物：7月10日获融资买入2107.80万元，
2025-07-11 - 国内首研20%皮下注射人免疫球蛋白（SCIG）：开
2025-07-10 - 2025年中国人纤维蛋白原行业主要应用范围、产业链
2025-07-10 - 天坛生物：7月9日获融资买入1896.92万元，占
2025-07-10 - 天坛生物：7月8日获融资买入4677.08万元
2025-07-09 - 天坛生物股价微跌0.61% 旗下新药获批填补市场空
2025-07-08 - 天坛生物：静注人免疫球蛋白（pH4）获药品补充申请
2025-07-08 - 天坛生物：7月7日获融资买入4858.01万元，占
2025-07-08 - 券商观点|医药生物行业定期报告：皮丙-血制品下一个
2025-07-07
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-05-28 |
| 一般消息 | 高管变动 | 撤销监事会 | 2025-05-27 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-05-10 |
| 一般消息 | 募资投向 | 2025-04-02 | |
| 利好 | 分红转增 | 10派1.0元(含税) | 2025-03-29 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 工作调整原因 | 2024-12-20 |
| 一般消息 | 高管变动 | 因工作调动原因 | 2024-11-28 |
| 一般消息 | 高管变动 | 因工作调动原因 | 2024-11-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.7行业面打败了94%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，跑赢大盘。
[{"date":"2025.07.11","price":"0.01","value":"1.39"},{"date":"2025.07.10","price":"0.48","value":"0.92"},{"date":"2025.07.09","price":"-0.13","value":"-0.28"},{"date":"2025.07.08","price":"0.70","value":"0.18"},{"date":"2025.07.07","price":"0.02","value":"-1.65"},{"date":"2025.07.04","price":"0.32","value":"0.46"},{"date":"2025.07.03","price":"0.18","value":"2.86"},{"date":"2025.07.02","price":"-0.09","value":"-1.57"},{"date":"2025.07.01","price":"0.39","value":"2.52"},{"date":"2025.06.30","price":"0.59","value":"1.47"},{"date":"2025.06.27","price":"-0.70","value":"0.85"},{"date":"2025.06.26","price":"-0.22","value":"-1.31"},{"date":"2025.06.25","price":"1.03","value":"0.29"},{"date":"2025.06.24","price":"1.15","value":"1.81"},{"date":"2025.06.23","price":"0.65","value":"1.50"},{"date":"2025.06.20","price":"-0.07","value":"0.27"},{"date":"2025.06.19","price":"-0.79","value":"-1.80"},{"date":"2025.06.18","price":"0.04","value":"-1.20"},{"date":"2025.06.17","price":"-0.04","value":"-1.63"},{"date":"2025.06.16","price":"0.35","value":"-0.12"},{"date":"2025.06.13","price":"-0.75","value":"-2.82"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 神州细胞 | 51.21% | -13.36% | 5.5分 |
| 2 | 康辰药业 | 35.44% | 27.28% | 5.5分 |
| 3 | 康华生物 | 25.74% | 13.22% | 5.0分 |
| 4 | 百普赛斯 | 19.06% | -1.95% | 5.0分 |
| 5 | 康泰生物 | 14.25% | 9.72% | 5.0分 |
| 6 | 沃森生物 | 13.43% | 4.23% | 5.0分 |
| 8 | 辽宁成大 | 8.77% | 5.90% | 5.3分 |
| 10 | 智飞生物 | 8.33% | 4.80% | 4.5分 |
| 12 | 金迪克 | 7.26% | 1.29% | 4.6分 |
| 14 | 优宁维 | 5.76% | 4.09% | 4.2分 |
| 16 | 华兰疫苗 | 5.20% | 2.14% | 4.6分 |
| 18 | 东宝生物 | 4.48% | 2.64% | 4.8分 |
| 20 | 博晖创新 | 4.01% | 4.19% | 4.6分 |
| 22 | 成大生物 | 3.78% | 1.95% | 5.3分 |
| 24 | 诺唯赞 | 3.17% | 2.99% | 5.7分 |
| 26 | 通化东宝 | 2.97% | -1.24% | 4.6分 |
| 28 | 艾迪药业 | 2.39% | 0.69% | 5.5分 |
| 30 | 天坛生物 | 1.71% | 1.34% | 5.0分 |
| 32 | 西藏药业 | 1.14% | 1.28% | 4.8分 |
| 34 | 百奥泰 | 0.84% | -2.43% | 5.3分 |
| 36 | 卫光生物 | 0.28% | -1.27% | 4.3分 |
| 38 | 华兰生物 | 0.13% | 0.63% | 4.6分 |
| 40 | 智翔金泰 | -0.34% | 0.61% | 5.0分 |
| 42 | 博雅生物 | -1.05% | 1.42% | 5.0分 |
| 44 | 三生国健 | -2.43% | 1.39% | 5.7分 |
| 46 | ST未名 | -4.16% | -17.31% | 4.1分 |
| 48 | 凯因科技 | -4.40% | 3.00% | 5.2分 |
| 50 | 长春高新 | -5.56% | -4.02% | 5.0分 |
| 52 | - | -14.94% | -0.12% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 10/72 ， 43/72。
[{"date":"2025-03-31","value":"2.17","vol":"0.63"},{"date":"2024-12-31","value":"14.78","vol":"-0.24"},{"date":"2024-09-30","value":"10.28","vol":"1.37"},{"date":"2024-06-30","value":"7.21","vol":"0.72"},{"date":"2024-03-31","value":"3.17","vol":"0.41"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.17 | 14.78 | 10.28 | 7.21 | 3.17 |
| 行业(%) | 0.63 | -0.24 | 1.37 | 0.72 | 0.41 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"45.87","vol":"69.78"},{"date":"2024-12-31","value":"54.70","vol":"69.97"},{"date":"2024-09-30","value":"55.33","vol":"70.57"},{"date":"2024-06-30","value":"55.67","vol":"69.89"},{"date":"2024-03-31","value":"56.08","vol":"70.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
45.87 | 54.70 | 55.33 | 55.67 | 56.08 |
| 行业(%) | 69.78 | 69.97 | 70.57 | 69.89 | 70.42 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 22/72 ， 33/72。
[{"date":"2025-03-31","value":"7.84","vol":"6246.12"},{"date":"2024-12-31","value":"16.44","vol":"48.20"},{"date":"2024-09-30","value":"1.28","vol":"178.44"},{"date":"2024-06-30","value":"5.59","vol":"19.75"},{"date":"2024-03-31","value":"-5.42","vol":"31.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
7.84 | 16.44 | 1.28 | 5.59 | -5.42 |
| 行业(%) | 6246.12 | 48.20 | 178.44 | 19.75 | 31.66 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-22.90","vol":"-7.36"},{"date":"2024-12-31","value":"39.58","vol":"-10.38"},{"date":"2024-09-30","value":"18.52","vol":"-53.42"},{"date":"2024-06-30","value":"28.10","vol":"-9.25"},{"date":"2024-03-31","value":"20.91","vol":"-535.57"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-22.90 | 39.58 | 18.52 | 28.10 | 20.91 |
| 行业(%) | -7.36 | -10.38 | -53.42 | -9.25 | -535.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 14/72 ， 28/72。
[{"date":"2025-03-31","value":"0.08","vol":"0.06"},{"date":"2024-12-31","value":"0.40","vol":"0.29"},{"date":"2024-09-30","value":"0.27","vol":"0.22"},{"date":"2024-06-30","value":"0.19","vol":"0.14"},{"date":"2024-03-31","value":"0.08","vol":"0.07"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.08 | 0.40 | 0.27 | 0.19 | 0.08 |
| 行业(次) | 0.06 | 0.29 | 0.22 | 0.14 | 0.07 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.18","vol":"0.26"},{"date":"2024-12-31","value":"0.81","vol":"1.19"},{"date":"2024-09-30","value":"0.58","vol":"0.87"},{"date":"2024-06-30","value":"0.42","vol":"0.55"},{"date":"2024-03-31","value":"0.18","vol":"0.26"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.18 | 0.81 | 0.58 | 0.42 | 0.18 |
| 行业(次) | 0.26 | 1.19 | 0.87 | 0.55 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-22.89","vol":"-47.52"},{"date":"2024-12-31","value":"-24.46","vol":"-9.01"},{"date":"2024-09-30","value":"7.47","vol":"-29.47"},{"date":"2024-06-30","value":"45.57","vol":"-36875.39"},{"date":"2024-03-31","value":"38.37","vol":"-44804.94"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -22.89 | -24.46 | 7.47 | 45.57 | 38.37 |
| 行业 | -47.52 | -9.01 | -29.47 | -36875.39 | -44804.94 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.94","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"3.24","vol":"2.72"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.94 | - | 3.24 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.72 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 36/72 ， 32/72。
[{"date":"2025-03-31","value":"7.19","vol":"7.90"},{"date":"2024-12-31","value":"6.89","vol":"6.83"},{"date":"2024-09-30","value":"5.51","vol":"7.16"},{"date":"2024-06-30","value":"5.22","vol":"7.04"},{"date":"2024-03-31","value":"5.53","vol":"8.08"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
7.19 | 6.89 | 5.51 | 5.22 | 5.53 |
| 行业 | 7.90 | 6.83 | 7.16 | 7.04 | 8.08 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"3.57","vol":"6.47"},{"date":"2024-12-31","value":"3.41","vol":"5.50"},{"date":"2024-09-30","value":"3.28","vol":"5.77"},{"date":"2024-06-30","value":"3.20","vol":"5.91"},{"date":"2024-03-31","value":"3.38","vol":"6.93"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.57 | 3.41 | 3.28 | 3.20 | 3.38 |
| 行业 | 6.47 | 5.50 | 5.77 | 5.91 | 6.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 38/72 ， 36/72。
[{"date":"2025-03-31","value":"8.41","vol":"25.48"},{"date":"2024-12-31","value":"8.42","vol":"25.46"},{"date":"2024-09-30","value":"10.96","vol":"24.92"},{"date":"2024-06-30","value":"11.44","vol":"24.62"},{"date":"2024-03-31","value":"10.85","vol":"23.98"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
8.41 | 8.42 | 10.96 | 11.44 | 10.85 |
| 行业(%) | 25.48 | 25.46 | 24.92 | 24.62 | 23.98 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.12","vol":"0.78"},{"date":"2024-12-31","value":"0.12","vol":"0.88"},{"date":"2024-09-30","value":"0.16","vol":"0.41"},{"date":"2024-06-30","value":"0.17","vol":"0.38"},{"date":"2024-03-31","value":"0.16","vol":"0.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.12 | 0.12 | 0.16 | 0.17 | 0.16 |
| 行业(%) | 0.78 | 0.88 | 0.41 | 0.38 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 招商证券 | 2025-05-16 | 增持 | |
| 万联证券 | 2025-05-06 | 买入 | |
| 兴业证券 | 2025-04-29 | 增持 | |
| 华源证券 | 2025-04-29 | 买入 | |
| 野村东方国际证券 | 2025-04-25 | 增持 | |
| 中信证券 | 2025-04-16 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"7.60","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.81","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.10","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"17.09","blueLineValue":"0.86","type":"YC"}]